Bellevue Hospital is a hospital in New York City and the oldest public hospital in the United States. One of the largest hospitals in the United States by number of beds, it is located at 462 First Avenue in the Kips Bay neighborhood of Manhattan, New York City.

There are 844 (2015) beds in Bellevue Hosp / New York Univ Med Ctr.

During the past decade, Bellevue Hosp / New York Univ Med Ctr conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 26 clinical trials were completed, i.e. on average, 55.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 14 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bellevue Hosp / New York Univ Med Ctr" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 106 trials, followed by "NYU Langone Health" with 53 trials sponsored, "Pfizer" with 4 trials sponsored, "AIDS Clinical Trials Group" with 2 trials sponsored and "Health Decisions" with 2 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bellevue Hosp / New York Univ Med Ctr" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 14 trials as a collaborator, "Bristol-Myers Squibb" with 10 trials as a collaborator, "Glaxo Wellcome" with 9 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 8 trials as a collaborator and "NYU Langone Health" with 7 trials as a collaborator. Other collaborators include 112 different institutions and companies that were collaborators in the rest 93 trials.

According to Clinical.Site data, the most researched conditions in "Bellevue Hosp / New York Univ Med Ctr" are "HIV Infections" (119 trials), "Pregnancy" (9 trials), "Schizophrenia" (6 trials), "Breast Cancer" (5 trials) and "Pneumonia, Pneumocystis Carinii" (5 trials). Many other conditions were trialed in "Bellevue Hosp / New York Univ Med Ctr" in a lesser frequency.

Most popular intervention types in "Bellevue Hosp / New York Univ Med Ctr" are "Drug" (133 trials), "Behavioral" (19 trials), "Other" (18 trials), "Device" (9 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (34 trials), "Didanosine" (16 trials), "Stavudine" (15 trials), "Nevirapine" (14 trials) and "Lamivudine" (13 trials). Other intervention names were less common.

The vast majority of trials in "Bellevue Hosp / New York Univ Med Ctr" are 181 trials for "All" genders, 23 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Bellevue Hosp / New York Univ Med Ctr". undefined are not yet recruiting, 17 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 160 completed trials in Bellevue Hosp / New York Univ Med Ctr, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Bellevue Hosp / New York Univ Med Ctr, 25 "Phase 1" clinical trials were conducted, 58 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 41 trials that are defined as “Not Applicable".